Effect of the protein kinase RNA-like endoplasmic reticulum kinase pathway in endoplasmic reticulum stress on hepatic stellate cell activation and collagen type I expression / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 968-974, 2024.
Article
em Zh
| WPRIM
| ID: wpr-1030789
Biblioteca responsável:
WPRO
ABSTRACT
ObjectiveTo investigate the effect of the protein kinase RNA-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2α (eIF2α) pathway in endoplasmic reticulum stress on the activation of hepatic stellate cells (HSC). MethodsPathological sections of normal liver tissue after surgery were collected from 11 patients with hepatic fibrosis (S1-S4) and 9 patients with hepatic hemangioma and hepatic adenoma confirmed by liver biopsy, and immunohistochemistry was used to measure the protein expression levels of PERK, eIF2α, and C/EBP homologous protein (CHOP). Human HSC-LX2 cells were treated with different concentrations of the endoplasmic reticulum stress inducer thapsigargin (0, 125, 250, 500, and 1 000 nmol/L), and qRT-PCR was used to measure the mRNA expression level of PERK, while Western blot was used to measure the protein expression levels of PERK, inositol requiring protein 1 (IRE1), activating transcription factor 6 (ATF6), CHOP, and α-smooth muscle actin (α-SMA). The method of lentivirus transfection was used to construct a PERK stable overexpression LX-2 group and a control group; qRT-PCR was used to measure the mRNA expression levels of PERK, eIF2α, and α-SMA, Western blot was used to measure the protein expression levels of PERK, phosphorylated eIF2α (p-eIF2α), and α-SMA, and immunofluorescence assay was used to measure the expression of collagen type I alpha 1 (COL1A1). The independent samples t-test was used for comparison of normally distributed continuous data between two groups; a one-way analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison between two groups. The Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups. ResultsCompared with normal liver tissue, the liver tissue of patients with hepatic fibrosis had significantly higher expression levels of PERK, eIF2α, and CHOP (Z=-3.56, t=-5.75, Z=-3.52, all P<0.001). Compared with the solvent group, the groups treated with different concentrations of thapsigargin had significant increases in the expression levels of the endoplasmic reticulum-associated proteins PERK, CHOP, IRE1, ATF6, and α-SMA (all P<0.05). Compared with the control group, the PERK stable overexpression group had significant increases in the mRNA expression levels of PERK, eIF2α, and α-SMA and the protein expression levels of PERK, p-eIF2α, and α-SMA (all P<0.05), and immunofluorescence assay showed a significant increase in the expression level of COL1A1 in the PERK stable overexpression group (P<0.05). ConclusionPERK overexpression can induce the expression of α-SMA and COL1A1 in LX-2 cells, suggesting that the PERK signaling pathway might be one of the important mechanisms of HSC activation.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Clinical Hepatology
Ano de publicação:
2024
Tipo de documento:
Article